The Network Virus MCTI (RedeVírus MCTI) is a committee that brings together specialists, government representatives, funding agencies, research centers and universities with the aim of integrating initiatives to combat emerging viruses.

Rede Vírus Internacional

The Ministry of Science, Technology, Innovations (MCTI) has mobilized research units, Institutes of Science and Technology and laboratories spread throughout the national territory in response to the emergence of the new coronavirus (Covid-19). These institutions work together in the development of diagnostics, treatments, vaccines and production of knowledge about the virus. The Network Virus MCTI (RedeVírus MCTI) is a committee that brings together specialists, government representatives, funding agencies, research centers and universities with the aim of integrating initiatives to combat emerging viruses. The Network functions as a strategic advisory committee that acts in the articulation of research laboratories, focusing on economic efficiency and on the optimization and complementarity of the infrastructure and research activities that are in progress, especially with the coronavirus. The Network Virus MCTI Committee counts expert researchers from several renowned research institutions such as Fiocruz, Butantan, USP, Unicamp, UFMG, UFC, CNPEM/LNBio/ MCTIC, UFRJ, among others.

Experts

The Committee of Experts on the Virus Network - MCTI is made up of renowned scientists, representatives of scientific societies and MCTI funding agencies, with the following composition:

1. 1. Afranio Lineu Kritski
   2. Aldo Ângelo Moreira Lima;
   3. Ana Paula Salles Moura Fernandes;
   4. Clarice Weis Arns;
   5. Edison Luiz Durigon;
   6. Esper Georges Kallás;
   7. Eurico de Arruda Neto;
   8. Fernanda Carvalho Mello;
   9. Fernando Rosado Spilki;
   10. Israel Molina Romero;
   11. Jorge Elias Kalil Filho;
   12. Luiz Ricardo Goulart Filho;
   13. Luiz Vicente Rizzo;
   14. Marco Aurélio Krieger;
   15. Marilda Agudo Mendonça Teixeira de Siqueira;
   16. Mauro Martins Teixeira;
   17. Patricia Rieken Macedo Rocco;
   18. Rafael Elias Marques Pereira Silva;
   19. Ricardo Tostes Gazzinelli;
   20. Valdiléa Gonçalves Veloso dos Santos;
   21. Viviane Fongaro Botosso.

Projects

Diagnosis

Project: “Implementation of rapid tests through nanotechnology for the new coronavirus in Brazil” Project: “Science and innovation to face the COVID-19 pandemic, through actions linked to the diagnosis of SARS-CoV-2” Project: “MCTIC Campaign Laboratories for diagnosing COVID-19 by RT-PCR

Medicines

Project: “Drug Repositioning and Structural Biology Sars-Cov-2″

Clinical trials

Project: "Effects of drug therapy selected from repositioning trials in patients with severe SARS-CoV-2-induced pneumonia" Project: “BCG use as prevention of Covid 19 in health professionals” Project: “Chloroquine chemoprophylaxis in a high-risk population for the prevention of SARS-CoV-2 infections / severity of infection. Phase III randomized clinical trial” Project: “Evaluation of the therapeutic regimen containing hydroxychloroquine and azithromycin for the treatment of pneumonia and acute respiratory failure associated with SARS-CoV-2” Project: “Treatment of patients with covid-19 with convalescent plasma transfusion multicentre, open, randomized and controlled study”

Vaccines

Project: “Development of vaccines against SARS-CoV-2”

Large-scale sequencing of the virus circulating in Brazil

Project: “Corona-ômica MCTI: National network of genomes, exome and transcriptome of COVID-19 to identify factors associated with the spread of the epidemic and severity”

Biobank

Project: “Structuring of SARS-CoV-2 sample bank”

Impacts of COVID-19

Project: “COVID-19 in Brazil: analysis and response to the social impacts of the pandemic among health professionals and the population in isolation” Project: “Immediate and long-term socio-economic impacts of Covid-19 in Brazil and its regions”